Brandon Daniell is one of several healthcare business leaders discussing the short- and long-term impact of COVID-19 on their companies in an article for SalientValue.
SalientValue is a bi-weekly newsletter distributed by VERTESS, a healthcare merger and acquisition (M&A) advisory firm.
Joining Daniell in sharing responses are leaders from a variety of companies, including an infection control consulting firm, managed services provider, developer of a drug shortage management platform, and medical supplies and equipment.
To access the article, click here.
